EV/EBITDA in the health & pharmaceuticals sector in Europe 2019-2023, by industry
Biotechnology drugs companies saw the highest EV/EBITDA multiple with 27.3 in 2023. Healthcare information and technology industry EV/EBITDA ratio decreased significantly from 42.2x in 2022 to 19.4x in 2023.